Altfest L J & CO Inc Abb Vie Inc. Transaction History

Altfest L J & CO Inc

$751 Million
Q3 2024

A detailed history of Altfest L J & CO Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Altfest L J & CO Inc holds 19,051 shares of ABBV stock, worth $3.37 Million. This represents 0.5% of its overall portfolio holdings.

Number of Shares

19,051

Previous 19,281 1.19%

Holding current value

$3.37 Million

Previous $3.31 Million 13.76%

% of portfolio

0.5%

Previous 0.45%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$163.84 - $199.33 $37,683 - $45,845	-230 Reduced 1.19%	19,051 $3.76 Million
Q2 2024 Aug 07, 2024	SELL	$154.79 - $180.76 $399,358 - $466,360	-2,580 Reduced 11.8%	19,281 $3.31 Million
Q1 2024 Apr 22, 2024	SELL	$159.82 - $182.1 $130,732 - $148,957	-818 Reduced 3.61%	21,861 $3.98 Million
Q4 2023 Jan 18, 2024	SELL	$137.6 - $154.97 $91,779 - $103,364	-667 Reduced 2.86%	22,679 $3.52 Million
Q3 2023 Oct 26, 2023	BUY	$133.59 - $154.65 $28,721 - $33,249	215 Added 0.93%	23,346 $3.48 Million
Q2 2023 Aug 09, 2023	BUY	$132.51 - $164.9 $40,945 - $50,954	309 Added 1.35%	23,131 $3.12 Million
Q1 2023 Apr 20, 2023	BUY	$144.61 - $166.54 $187,559 - $216,002	1,297 Added 6.03%	22,822 $3.64 Million
Q4 2022 Feb 02, 2023	SELL	$138.31 - $165.87 $24,342 - $29,193	-176 Reduced 0.81%	21,525 $3.48 Million
Q3 2022 Nov 15, 2022	BUY	$134.21 - $153.93 $40,665 - $46,640	303 Added 1.42%	21,701 $2.91 Million
Q2 2022 Aug 04, 2022	BUY	$137.62 - $174.96 $12,936 - $16,446	94 Added 0.44%	21,398 $3.28 Million
Q1 2022 May 02, 2022	SELL	$131.98 - $163.75 $25,604 - $31,767	-194 Reduced 0.9%	21,304 $3.45 Million
Q4 2021 Jan 24, 2022	SELL	$107.43 - $135.93 $29,758 - $37,652	-277 Reduced 1.27%	21,498 $2.91 Million
Q3 2021 Oct 12, 2021	BUY	$106.4 - $120.78 $308,985 - $350,745	2,904 Added 15.39%	21,775 $2.35 Million
Q2 2021 Jul 28, 2021	BUY	$105.21 - $117.21 $9,363 - $10,431	89 Added 0.47%	18,871 $2.13 Million
Q1 2021 May 07, 2021	BUY	$102.3 - $112.62 $17,288 - $19,032	169 Added 0.91%	18,782 $2.03 Million
Q4 2020 Jan 21, 2021	BUY	$80.49 - $108.67 $191,485 - $258,525	2,379 Added 14.65%	18,613 $1.99 Million
Q3 2020 Oct 29, 2020	BUY	$85.91 - $100.83 $34,879 - $40,936	406 Added 2.57%	16,234 $1.42 Million
Q2 2020 Jul 21, 2020	SELL	$73.37 - $98.18 $29,788 - $39,861	-406 Reduced 2.5%	15,828 $1.55 Million
Q1 2020 Apr 13, 2020	BUY	$64.5 - $97.79 $32,959 - $49,970	511 Added 3.25%	16,234 $1.24 Million
Q4 2019 Jan 06, 2020	SELL	$72.13 - $90.25 $112,450 - $140,699	-1,559 Reduced 9.02%	15,723 $1.39 Million
Q3 2019 Oct 10, 2019	BUY	$62.98 - $75.72 $16,122 - $19,384	256 Added 1.5%	17,282 $1.31 Million
Q2 2019 Jul 15, 2019	BUY	$65.7 - $83.98 $289,868 - $370,519	4,412 Added 34.98%	17,026 $1.24 Million
Q1 2019 Jun 10, 2019	SELL	$77.14 - $90.79 $32,167 - $37,859	-417 Reduced 3.2%	12,614 $1.02 Million
Q1 2019 May 24, 2019	BUY	$77.14 - $90.79 $378,680 - $445,688	4,909 Added 60.44%	13,031 $1.2 Million
Q1 2019 Apr 05, 2019	SELL	$77.14 - $90.79 $393,722 - $463,392	-5,104 Reduced 38.59%	8,122 $1.25 Million
Q4 2018 Jan 15, 2019	SELL	$77.85 - $96.01 $630,974 - $778,161	-8,105 Reduced 38.0%	13,226 $1.22 Million
Q3 2018 Oct 10, 2018	SELL	$88.91 - $98.84 $22,049 - $24,512	-248 Reduced 1.15%	21,331 $2.02 Million
Q2 2018 Aug 07, 2018	BUY	$89.78 - $106.23 $185,754 - $219,789	2,069 Added 10.6%	21,579 $2 Million
Q1 2018 May 10, 2018	SELL	$92.01 - $123.21 $151,172 - $202,434	-1,643 Reduced 7.77%	19,510 $1.85 Million
Q4 2017 Feb 12, 2018	SELL	$89.56 - $98.21 $36,182 - $39,676	-404 Reduced 1.87%	21,153 $2.05 Million
Q3 2017 Oct 23, 2017	BUY	$69.85 - $89.22 $1.51 Million - $1.92 Million	21,557	21,557 $1.92 Million

Others Institutions Holding ABBV

# of Institutions

3,848

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $313B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Altfest L J & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Altfest L J & CO Inc with notifications on news.

Account